# Effects of Closed-loop Automatic Control of FiO2 in Extremely Preterm Infants

> **NCT03168516** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **University Hospital Tuebingen** · enrollment: 1065 (actual)

## Conditions studied

- Infant,Premature

## Interventions

- **DEVICE:** closed-loop automatic control of the inspiratory fraction of oxygen (FiO2-C)

## Key facts

- **NCT ID:** NCT03168516
- **Lead sponsor:** University Hospital Tuebingen
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-07-27
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 1065 (ACTUAL)
- **Last updated:** 2023-12-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03168516

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03168516, "Effects of Closed-loop Automatic Control of FiO2 in Extremely Preterm Infants". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT03168516. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*